Epocrates, Inc. IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
  FREE IPO Newsletter
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  2017 IPOs
    IPO Pricings
    Industry Breakdown
  2016 IPOs
  2015 IPOs
  2014 IPOs
  2013 IPOs
  2012 IPOs
  Sample IPO
  Rating Scale
  IPO Primer
  Current Week
  Track Record
  2017 Secondaries
  2016 Secondaries
  Secondaries Primer
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Site Map

For IPO Boutique's "scale of 1 to 5" BUY rating on Epocrates, Inc., and our comprehensive analysis, click the "Buy Market Research" link.
Price Range
Issue Price
Trade Date
Epocrates, Inc.EPOC $16.00 $0.002011-02-02
J.P. Morgan
Health Care

Epocrates, Inc. Historical Chart - Click chart for current quote

About Epocrates, Inc. (adapted from Epocrates, Inc. prospectus):
Epocrates is a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry. Most commonly used on mobile devices at the point of care, our products help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity. Our user network consists of over one million healthcare professionals, including over 300,000, or over 45% of, U.S. physicians. We offer our products on all major U.S. mobile platforms including Apple® (iPhone®, iPod touch® and iPad®), Android, BlackBerry®, Palm® and Windows® Mobile devices. To date, we have worked with all of the top 20 global pharmaceutical companies by sales and over 350 individual pharmaceutical brands to engage with healthcare professionals through our interactive services.

This description is adapted from Epocrates prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as Epocrates "EPOC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription —

© 2005 - 2017 IPO Boutique. All Rights Reserved